Parkinson’s UK comments on new drawing test to assess people with Parkinson’s disease

NewsGuard 100/100 Score

A paper published today in Frontiers in Neurology outlines a trial of a drawing test that could help assess people with Parkinson’s. In the trial, volunteers were asked to draw a spiral. By analyzing how long it took them to draw the spiral and how hard they pressed on the paper with the pen, researchers could not only tell which volunteers had Parkinson’s, but how far their condition had progressed.

Commenting on the paper, David Dexter, Deputy Research Director at Parkinson’s UK, said:

Current tests for Parkinson’s cannot accurately measure how advanced someone’s condition is. This can impact on the ability to select the right people for clinical research, which is essential to develop new and better treatments for Parkinson’s. The test could also measure the condition’s progression.

This new test could provide a more accurate assessment by measuring a wider range of features that may be affected by Parkinson’s, such as co-ordination, pressure, speed and cognitive function.

If proven to be effective, this could be a stepping stone to better, more successful clinical trials for Parkinson’s.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research from NY highlights pollution as a key factor in rising cancer rates among youth